Polyphenol-rich natural products have been associated to protective activities towards several chronic diseases. The exploitation of polyphenols as sources of molecules with nutraceutical/pharmacological interest depends on effective methods for compounds extraction to be further tested as regard their chemical and biological activities. Additionally, the use of fractionation procedures coordinated with bioactivity/antimicrobial screenings -bio-guided fractionation -is required for the identification of single compounds with therapeutic potential. Once identified, the pharmacokinetics and modus operandi of compounds need to be gathered to support the rational design and synthesis of medicinal chemistry derivatives. Alternatively, large-scale production of potential bioactive polyphenols can be achieved by means of synthetic biology. At last, technologies of controlled delivery must ensure that the compounds are carried to the site of action. The ultimate goal of this pipeline is to discover and make available to society therapeutic alternatives for chronic diseases including cancer, neurodegenerative, cardiovascular, and metabolic diseases.
